Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Binder

Showing results (161-170 of 219) with videos related to

Pageof 22
Sort By:
Thrombosis and Haemostasis|February 3, 1992
A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosisK Huber, M Jörg, P Probst, et al.
Blood|July 1, 1994
Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cellsJ Wojta, T Nakamura, A Fabry, et al.
Blood|July 1, 1989
A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitorC L Gladson, R R Schleef, B R Binder, et al.
The Journal of Biological Chemistry|April 5, 1992
Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding proteinS Ecke, M Geiger, I Resch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998
Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel diseaseA Geppert, S Graf, R Beckmann, et al.
Biochemical Pharmacology|February 1, 1990
Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and manM Maier, G Reissert, I Jerabek, et al.
Blood|March 10, 2001
Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuliW Oitzinger, R Hofer-Warbinek, J A Schmid, et al.
Blood|August 1, 1989
Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivoM Geiger, K Huber, J Wojta, et al.
Thrombosis Research|May 21, 1999
Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplastyR E Roller, S Janisch, V Carroll, et al.
Physiological Research|October 24, 2007
Some endocrine traits of transgenic rabbits. I. Changes in plasma and milk hormonesA V Sirotkin, P Chrenek, J Rafay, et al.
Pageof 22

Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|February 3, 1992
A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosisK Huber, M Jörg, P Probst, et al.
Blood|July 1, 1994
Hepatocyte growth factor stimulates expression of plasminogen activator inhibitor type 1 and tissue factor in HepG2 cellsJ Wojta, T Nakamura, A Fabry, et al.
Blood|July 1, 1989
A comparison between activated protein C and des-1-41-light chain-activated protein C in reactions with type 1 plasminogen activator inhibitorC L Gladson, R R Schleef, B R Binder, et al.
The Journal of Biological Chemistry|April 5, 1992
Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding proteinS Ecke, M Geiger, I Resch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998
Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel diseaseA Geppert, S Graf, R Beckmann, et al.
Biochemical Pharmacology|February 1, 1990
Release of [hydroxyproline3]-kinins by tissue kallikreins of pig, rat and manM Maier, G Reissert, I Jerabek, et al.
Blood|March 10, 2001
Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuliW Oitzinger, R Hofer-Warbinek, J A Schmid, et al.
Blood|August 1, 1989
Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivoM Geiger, K Huber, J Wojta, et al.
Thrombosis Research|May 21, 1999
Changes in the fibrinolytic system in patients with peripheral arterial occlusive disease undergoing percutaneous transluminal angioplastyR E Roller, S Janisch, V Carroll, et al.
Physiological Research|October 24, 2007
Some endocrine traits of transgenic rabbits. I. Changes in plasma and milk hormonesA V Sirotkin, P Chrenek, J Rafay, et al.
Pageof 22